Verona: A breakthrough in COPD treatment is ready. Favorable financial situation (VRNA)

athletics racing sports

Rudy Silva/E+ via Getty Images


Verona Pharma (Nasdaq: VRNA) is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative treatments for respiratory diseases with unmet medical need. Their lead experimental product, Encifenthrin, is a breakthrough compound targeting chronic obstructive disease.

Data from YCharts

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *